Tower Research Capital LLC (Trc) Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Tower Research Capital LLC (Trc)

$5.8 Billion
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$144.95 - $152.29 $144,805 - $152,137	-999 Reduced 14.42%	5,928 $896,000
Q2 2022 Aug 15, 2022	BUY	$83.14 - $145.99 $433,242 - $760,753	5,211 Added 303.67%	6,927 $1.01 Million
Q1 2022 May 12, 2022	SELL	$110.08 - $142.92 $86,632 - $112,478	-787 Reduced 31.44%	1,716 $204,000
Q4 2021 Feb 14, 2022	BUY	$99.73 - $148.48 $58,441 - $87,009	586 Added 30.57%	2,503 $344,000
Q3 2021 Nov 15, 2021	SELL	$98.85 - $138.91 $356,156 - $500,492	-3,603 Reduced 65.27%	1,917 $266,000
Q2 2021 Aug 16, 2021	BUY	$65.78 - $105.02 $84,066 - $134,215	1,278 Added 30.13%	5,520 $536,000
Q1 2021 May 17, 2021	SELL	$64.07 - $91.75 $115,133 - $164,874	-1,797 Reduced 29.76%	4,242 $290,000
Q4 2020 Feb 16, 2021	SELL	$65.07 - $98.24 $412,478 - $622,743	-6,339 Reduced 51.21%	6,039 $517,000
Q3 2020 Nov 16, 2020	BUY	$59.04 - $77.95 $493,456 - $651,506	8,358 Added 207.91%	12,378 $805,000
Q2 2020 Aug 13, 2020	BUY	$29.01 - $74.23 $96,516 - $246,963	3,327 Added 480.09%	4,020 $294,000
Q1 2020 May 15, 2020	BUY	$27.51 - $57.29 $18,954 - $39,472	689 Added 17225.0%	693 $24,000
Q4 2019 Feb 07, 2020	SELL	$40.86 - $57.65 $68,563 - $96,736	-1,678 Reduced 99.76%	4 $0
Q3 2019 Nov 05, 2019	BUY	$37.38 - $49.47 $7,700 - $10,190	206 Added 13.96%	1,682 $70,000
Q2 2019 Aug 13, 2019	BUY	$39.79 - $67.01 $58,730 - $98,906	1,476 New	1,476 $65,000
Q1 2019 May 14, 2019	SELL	$34.52 - $53.29 $119,784 - $184,916	-3,470 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$29.75 - $42.9 $47,213 - $68,082	-1,587 Reduced 31.38%	3,470 $128,000
Q3 2018 Nov 13, 2018	BUY	$32.79 - $43.0 $142,210 - $186,491	4,337 Added 602.36%	5,057 $190,000
Q2 2018 Aug 15, 2018	SELL	$23.62 - $42.29 $8,692 - $15,562	-368 Reduced 33.82%	720 $28,000
Q1 2018 May 15, 2018	BUY	$22.49 - $34.56 $24,469 - $37,601	1,088 New	1,088 $28,000
Q4 2017 Feb 09, 2018	SELL	$20.44 - $35.56 $20,644 - $35,915	-1,010 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$23.54 - $38.21 $23,775 - $38,592	1,010	1,010 $38,000

Others Institutions Holding BHVN

# of Institutions

Shares Held

785K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account